Los puntos clave no están disponibles para este artículo en este momento.
LOLA benefited patients with overt hepatic encephalopathy (I or II), whereas these data do not support the use of LOLA for patients with subclinical hepatic encephalopathy.
Building similarity graph...
Analyzing shared references across papers
Loading...
Qian Jiang
Yantai University
Xuehua Jiang
Sichuan University
Ming‐Hua Zheng
Wenzhou Medical University
Journal of Gastroenterology and Hepatology
Sichuan University
Wenzhou Medical University
First Affiliated Hospital of Wenzhou Medical University
Building similarity graph...
Analyzing shared references across papers
Loading...
Jiang et al. (Wed,) studied this question.
synapsesocial.com/papers/69d80bfca2a48916bbbeeb57 — DOI: https://doi.org/10.1111/j.1440-1746.2008.05582.x
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: